Dong-A ST Co., Ltd.
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Public
- Established
- 1932-01-01
- Employees
- 1.6K
- Market Cap
- -
- Website
- http://www.donga-st.com
A Study to Evaluate the Effects of Renal Function on Pharmacokinetics and Safety of DA-8010
- First Posted Date
- 2023-04-13
- Last Posted Date
- 2024-06-26
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 33
- Registration Number
- NCT05812417
- Locations
- 🇰🇷
CHA Bundang Medical Center, Gyeonggi-do, Korea, Republic of
Clinical Trial to Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing Metformin Monotherapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control
- First Posted Date
- 2023-02-24
- Last Posted Date
- 2024-02-16
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 232
- Registration Number
- NCT05743907
- Locations
- 🇰🇷
The Catholic University of Korea Bucheon St. Mary's Hospital, Bucheon, Korea, Republic of
Phamacokinetics and Safety Profiles of DA-1229_01 2.5/500mg in Healthy Subjects at Fed State
Phase 1
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-02-22
- Last Posted Date
- 2023-02-22
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 34
- Registration Number
- NCT05739877
- Locations
- 🇰🇷
Metro Hospital, Anyang-si, Gyeonggi-do, Korea, Republic of
Phamacokinetics and Safety Profiles of DA-1229_01 2.5/500mg in Healthy Subjects at Fasting State
Phase 1
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-02-22
- Last Posted Date
- 2023-02-22
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT05739851
- Locations
- 🇰🇷
Metro Hospital, Anyang-si, Gyeonggi-do, Korea, Republic of
Phamacokinetics and Safety Profiles of DA-1229_01 5/1000mg in Healthy Subjects at Fasting State
Phase 1
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-02-22
- Last Posted Date
- 2023-02-22
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT05739903
- Locations
- 🇰🇷
Metro Hospital, Anyang-si, Gyeonggi-do, Korea, Republic of
Phamacokinetics and Safety Profiles of DA-1229_01 5/1000mg in Healthy Subjects at Fed State
Phase 1
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-02-22
- Last Posted Date
- 2023-02-22
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 34
- Registration Number
- NCT05739916
- Locations
- 🇰🇷
Metro Hospital, Anyang-si, Gyeonggi-do, Korea, Republic of
Efficacy and Safety of Actonel® After Denosumab Discontinuation in Postmenopausal Osteoporosis Women
Phase 4
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-11-30
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 155
- Registration Number
- NCT05630768
- Locations
- 🇰🇷
Severance Hospital, Seoul, Seodaemun-gu, Korea, Republic of
A Clinical Trial to Compare the Safety, Tolerability, and PK Properties of DA-5216 and DA-5216-R and to Evaluate the Food Effect on DA-5216.
- First Posted Date
- 2022-08-18
- Last Posted Date
- 2022-09-23
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 88
- Registration Number
- NCT05506007
- Locations
- 🇰🇷
Seoul National University Hospital, Soeul, Korea, Republic of
Pharmacokinetics and Safety Profiles After Administration of DA-5218 and Co-administration of DA-5218-R1, DA-5218-R2 and DA-5218-R3 in Healthy Adult Volunteers
- First Posted Date
- 2022-07-08
- Last Posted Date
- 2022-07-08
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 90
- Registration Number
- NCT05449704
- Locations
- 🇰🇷
Bumin Hospital, Seoul, Korea, Republic of
Bioequivalence Study Between "DA-5215 Tab" and "DA-5215-R Tab"
- First Posted Date
- 2022-05-17
- Last Posted Date
- 2022-05-17
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 50
- Registration Number
- NCT05376085
- Locations
- 🇰🇷
H Plus Yangji Hospital, Seoul, Korea, Republic of
© Copyright 2024. All Rights Reserved by MedPath